Skip to main content

John A. Donofrio, Jr.

Equibles does not estimate personal net worth.

Get an email with a short summary when Aytu Biopharma, Inc publishes a filing, an earnings call transcript or a press release.

Get AYTU alerts

About John A. Donofrio, Jr.

John A. Donofrio, Jr. is recorded as Chairman at Aytu Biopharma, Inc (AYTU) since November 6, 2024. Aytu Biopharma, Inc reported in an 8-K filed November 13, 2024 that John A. Donofrio, Jr. was appointed Chairman of the Board of Directors, effective November 6, 2024. Aytu Biopharma, Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Aytu Biopharma, Inc includes Joshua R. Disbrow (CEO and Board Member), Gregory A. Gould (CFO), Ryan Selhorn (CFO) and 7 others.

“On November 6, 2024, the Company's Board determined to separate the roles of Chairman of the Board of Directors and Chief Executive Officer and appointed director John A. Donofrio, Jr. as Chairman of the Board of Directors of the Company, replacing Joshua R. Disbrow in the role.”
Aytu Biopharma, Inc Form 8-K, filed November 13, 2024 · Read the filing

Affiliation history

Company network

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Chairman

2024-11-06–present

Leadership on record at Aytu Biopharma, Inc

Recent activity